Zealand
Theis Gondolf currently serves as Senior Medical Director at Zealand Pharma since April 2023, following an extensive tenure at Novo Nordisk from January 2015 to March 2023, where roles included Medical Director in Metabolism and International Medical Director for Devices & Digital Health. Prior experience includes various positions such as Head of Medical Affairs at Novo Nordisk Denmark A/S and Staff Specialist in emergency services and general practice across multiple healthcare facilities in Denmark. Theis Gondolf's medical training includes degrees from the University of Copenhagen, culminating in a Specialist in General Medicine from The Capital Region of Denmark.